Integrated Filing — IndAS

General information about company
Scrip Code	543330
NSE Symbol	DEVYANI
MSEI Symbol	NOTLISTED
ISIN	INE872J01023
Name of company	Devyani International Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	23-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	16-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Food and Beverages
Start date and time of board meeting	23-May-2025   11:00:00
End date and time of board meeting	23-May-2025   11:40:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-02-11
Indicate Company website link for updated RPT policy of the Company	https://dil-rjcorp.com/wp-content/uploads/2021/06/Policy-on-Related-Party-Transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	8012250000	33493330000
	Other income	144900000	498830000
	Total income	8157150000	33992160000
2	Expenses
(a)	Cost of materials consumed	2308390000	9509040000
(b)	Purchases of stock-in-trade	12990000	56600000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	1019530000	4549540000
(e)	Finance costs	586390000	2214100000
(f)	Depreciation, depletion and amortisation expense	1084980000	4036110000
(f)	Other Expenses
1	Impairment of non-current assets	133740000	223030000
2	Other expenses	3167220000	13133410000
	Total other expenses	3300960000	13356440000
	Total expenses	8313240000	33721830000
3	Total profit before exceptional items and tax	-156090000	270330000
4	Exceptional items	0	0
5	Total profit before tax	-156090000	270330000
6	Tax expense
7	Current tax	26900000	201460000
8	Deferred tax	-50350000	-168320000
9	Total tax expenses	-23450000	33140000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-132640000	237190000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-132640000	237190000
17	Other comprehensive income net of taxes	2020000	-4000000
18	Total Comprehensive Income for the period	-130620000	233190000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	1206270000	1206270000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		0
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-0.11	0.2
	Diluted earnings (loss) per share from continuing operations	-0.11	0.2
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-0.11	0.2
	Diluted earnings (loss) per share from continuing and discontinued operations	-0.11	0.2
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Notes to consolidated and standalone financial results for the quarter and year ended 31 March 2025tttt n n1.tIn terms of Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements 2015, as amended, these consolidated and standalone financial results financial results for the quarter and year ended 31 March 2025 have been reviewed and recommended for approval by the Audit, Risk Management and Ethics Committee and accordingly have been approved by the Board of Directors of Devyani International Limited DIL or the Company at their respective meetings held on 23 May 2025. The joint statutory auditors have audited these annual financial results. n2.tThe figures for the quarter ended 31 March 2025 and 31 March 2024 are the balancing figures between the audited figures for the full financial year and the unaudited year to date figures up to the end of third quarter of the respective financial years, which were subjected to a limited review by the statutory auditors. n3.tThese financial results have been prepared in accordance with the recognition and measurement principles of applicable Indian Accounting Standards Ind AS notified under the Companies Indian Accounting Standards Rules, 2015 as specified in Section 133 of the Companies Act, 2013 read with SEBI Circular CIRCFDFAC622016 dated 05 July 2016 and other recognised accounting practices and policies. n4.tDuring the current quarter and subsequent to the current quarter, 70,000 Employee Stock Options Options and 18,82,500 Options were exercised by the employees under the Employees Stock Option Scheme 2021 of the Company, respectively, against which, 19,52,500 equity shares of INR 1/- each were allotted subsequent to the current quarter. n5.tSubsequent to the current quarter, the Board of Directors of the Company on 24 April 2025, has approved acquisition of up to 80.72% equity stake, on fully diluted basis, in Sky Gate Hospitality Private Limited excluding the business of Krazy Kebab Co. and its investment in Peanutbutter for a total consideration of INR 4,196.00. n6.tThe Group operates in single reportable business segment food and beverages in terms of Ind AS 108- Segment Reporting. n7.tThe previous period year numbers have been regrouped reclassified wherever necessary to conform to current period year presentation. The impact of such reclassification regrouping have been accordingly considered and not material to the financial results.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	11921370000
	Capital work-in-progress	34570000
	Investment property	259240000
	Goodwill	504570000
	Other intangible assets	18000170000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	3536390000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	1144940000
	Total non-current financial assets	4681330000
	Deferred tax assets (net)	1286190000
	Other non-current assets	117900000
	Total non-current assets	36805340000
2	Current assets
	Inventories	1068840000
	Current financial asset
	Current investments	25110000
	Trade receivables, current	585300000
	Cash and cash equivalents	234570000
	Bank balance other than cash and cash equivalents	0
	Loans, current	0
	Other current financial assets	483620000
	Total current financial assets	1328600000
	Current tax assets (net)	0
	Other current assets	440210000
	Total current assets	2837650000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	39642990000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	1206270000
	Other equity	9833400000
	Total equity attributable to owners of parent	11039670000
	Non controlling interest
	Total equity	11039670000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	2645070000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	18548450000
	Total non-current financial liabilities	21193520000
	Provisions, non-current	212500000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	20920000
	Total non-current liabilities	21426940000
	Current liabilities
	Current financial liabilities
	Borrowings, current	1074970000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	163010000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	2761540000
	Total Trade payable	2924550000
	Other current financial liabilities	2607500000
	Total current financial liabilities	6607020000
	Other current liabilities	459630000
	Provisions, current	109730000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	7176380000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	28603320000
	Total equity and liabilites	39642990000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
	Total Amount of items that will not be reclassified to profit and loss
2	Income tax relating to items that will not be reclassified to profit or loss	-2700000	5340000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	680000	-1340000
5	Total Other comprehensive income	2020000	-4000000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			270330000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			2214100000
	Adjustments for decrease (increase) in inventories			-231730000
	Adjustments for decrease (increase) in trade receivables, current			-139970000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			23900000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			591380000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			4036110000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			223030000
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-9960000
	Adjustments for dividend income			26440000
	Adjustments for interest income			124510000
	Adjustments for share-based payments			-92110000
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-920000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-152250000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			6310630000
	Net cash flows from (used in) operations			6580960000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			-43830000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			6624790000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			86100000
	Purchase of property, plant and equipment			3505760000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			920000
	Purchase of other long-term assets			16920000
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			6990000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			199470000
	Net cash flows from (used in) investing activities	-3229200000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			9550000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			570680000
	Repayments of borrowings			511500000
	Payments of lease liabilities			3069640000
	Dividends paid			0
	Interest paid			272970000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			3030000
	Net cash flows from (used in) financing activities			-3270850000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			124740000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			124740000
	Cash and cash equivalents cash flow statement at beginning of period			0
	Cash and cash equivalents cash flow statement at end of period			124740000